Saturday, July 11, 2026

biotech · Locally Advanced Breast Cancer (LABC) · Mantle Cell Lymphoma

Beijing Luzhu Biopharmaceutical

Beijing Zhifei Lvzhu is a biotech organization headquartered in CN. Primary therapeutic focus areas include Locally Advanced Breast Cancer (LABC), Mantle Cell Lymphoma, Systemic Lupus Erythematosus, Meningitis, Pneumococ

Beijing, CN HQ
2 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Beijing, CN
Employees
2
Programs
7
Drugs
5
Patents
0
Clinical program

Vagus Nerve Stimulation

Phase 1 · other · Refractory Epilepsy

Vagus Nerve Stimulation for Refractory Epilepsy is a Phase 1 program (other) at Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd with 1 ClinicalTrials.gov record(s).

Internal code PINS-012

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd
Phase
Phase 1
Modality
other
Indication
Refractory Epilepsy
Status
active
Trials
1

Clinical trials